1. Home
  2. AMPH
  3. AMPH News

Latest Amphastar Pharmaceuticals Inc. (AMPH) News on April 2, 2025

International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award
AMPH

ACCESS Newswire

5 days ago

International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award

AMPH

Argus Research

7 days ago

AMPH: Raising target price to $31.00

Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks
AMPH

StockStory

20 days ago

Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference
AMPH

ACCESS Newswire

a month ago

Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference

Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers
AMPH

StockStory

a month ago

Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers

AMPH

Argus Research

a month ago

AMPH: Lowering target price to $29.00

Amphastar Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations
AMPH

Simply Wall St.

a month ago

Amphastar Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations

Is Amphastar Pharmaceuticals, Inc. (AMPH) the Best Small Cap Pharma Stocks to Buy Now?
AMPH

Insider Monkey

a month ago

Is Amphastar Pharmaceuticals, Inc. (AMPH) the Best Small Cap Pharma Stocks to Buy Now?

Specialty Pharma Amphastar Stock Falls On Lower Than Expected Q4 Earnings, Analyst Sees Competitive Headwinds
AMPH

Benzinga

a month ago

Specialty Pharma Amphastar Stock Falls On Lower Than Expected Q4 Earnings, Analyst Sees Competitive Headwinds

AMPH

GuruFocus.com

a month ago

Amphastar Pharmaceuticals Inc (AMPH) Q4 2024 Earnings Call Highlights: Revenue Growth and ...

Amphastar (AMPH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
AMPH

Zacks

a month ago

Amphastar (AMPH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Lag Estimates
AMPH

Zacks

a month ago

Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Lag Estimates

AMPH

Associated Press Finance

a month ago

Amphastar: Q4 Earnings Snapshot

Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q4 Sales Targets, Stock Drops 12.1%
AMPH

StockStory

a month ago

Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q4 Sales Targets, Stock Drops 12.1%

Amphastar Pharmaceuticals' (NASDAQ:AMPH) 15% CAGR outpaced the company's earnings growth over the same five-year period
AMPH

Simply Wall St.

a month ago

Amphastar Pharmaceuticals' (NASDAQ:AMPH) 15% CAGR outpaced the company's earnings growth over the same five-year period

Earnings To Watch: Amphastar Pharmaceuticals (AMPH) Reports Q4 Results Tomorrow
AMPH

StockStory

a month ago

Earnings To Watch: Amphastar Pharmaceuticals (AMPH) Reports Q4 Results Tomorrow

AMPH

GuruFocus.com

a month ago

Amphastar Pharmaceuticals Inc (AMPH) Q4 2024 Earnings Report Preview: What To Look For

AMPH

Argus Research

a month ago

AMPH: Raising target price to $34.00

Q3 Earnings Outperformers: Viatris (NASDAQ:VTRS) And The Rest Of The Generic Pharmaceuticals Stocks
AMPH

StockStory

a month ago

Q3 Earnings Outperformers: Viatris (NASDAQ:VTRS) And The Rest Of The Generic Pharmaceuticals Stocks

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025
AMPH

ACCESS Newswire

a month ago

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025

Generic Pharmaceuticals Stocks Q3 Teardown: Amneal (NASDAQ:AMRX) Vs The Rest
AMPH

StockStory

a month ago

Generic Pharmaceuticals Stocks Q3 Teardown: Amneal (NASDAQ:AMRX) Vs The Rest

AMPH

Argus Research

a month ago

AMPH: Lowering target price to $32.00

Unpacking Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) In The Context Of Other Generic Pharmaceuticals Stocks
AMPH

StockStory

2 months ago

Unpacking Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) In The Context Of Other Generic Pharmaceuticals Stocks

ANI Pharmaceuticals (NASDAQ:ANIP): Strongest Q3 Results from the Generic Pharmaceuticals Group
AMPH

StockStory

2 months ago

ANI Pharmaceuticals (NASDAQ:ANIP): Strongest Q3 Results from the Generic Pharmaceuticals Group

AMPH

Argus Research

2 months ago

AMPH: Lowering target price to $35.00

AMPH

MT Newswires

2 months ago

Piper Sandler Downgrades Amphastar Pharmaceuticals to Neutral From Overweight, Adjusts Price Target to $36 From $66

AMPH

MT Newswires

2 months ago

BofA Adjusts Price Target on Amphastar Pharmaceuticals to $44 From $46

AMPH

Argus Research

2 months ago

AMPH: Raising target price to $39.00

AMPH

Argus Research

2 months ago

AMPH: Lowering target price to $38.00

AMPH

Argus Research

3 months ago

AMPH: Raising target price to $40.00

Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
AMPH

ACCESSWIRE

3 months ago

Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

AMPH

Argus Research

3 months ago

AMPH: Lowering target price to $41.00

AMPH

Argus Research

3 months ago

AMPH: Lowering target price to $43.00

AMPH

MT Newswires

4 months ago

Amphastar Pharmaceuticals Insider Sold Shares Worth $672,815, According to a Recent SEC Filing

AMPH

Argus Research

4 months ago

AMPH: Lowering target price to $46.00

Should You Be Adding Amphastar Pharmaceuticals (NASDAQ:AMPH) To Your Watchlist Today?
AMPH

Simply Wall St.

4 months ago

Should You Be Adding Amphastar Pharmaceuticals (NASDAQ:AMPH) To Your Watchlist Today?

Implied Volatility Surging for Amphastar Pharmceuticals (AMPH) Stock Options
AMPH

Zacks

4 months ago

Implied Volatility Surging for Amphastar Pharmceuticals (AMPH) Stock Options

AMPH

Argus Research

4 months ago

AMPH: Raising target price to $47.00

Why Amphastar Pharmaceuticals (AMPH) Is One of the Most Profitable Pharmaceutical Stocks Right Now?
AMPH

Insider Monkey

4 months ago

Why Amphastar Pharmaceuticals (AMPH) Is One of the Most Profitable Pharmaceutical Stocks Right Now?

AMPH

Argus Research

4 months ago

AMPH: What does Argus have to say about AMPH?

Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference
AMPH

ACCESSWIRE

4 months ago

Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference

Amphastar initiated with an Equal Weight at Wells Fargo
AMPH

TipRanks

4 months ago

Amphastar initiated with an Equal Weight at Wells Fargo

Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference
AMPH

ACCESSWIRE

5 months ago

Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference

AMPH

Argus Research

5 months ago

AMPH: Lowering target price to $50.00

Amphastar Pharmaceuticals Third Quarter 2024 Earnings: Misses Expectations
AMPH

Simply Wall St.

5 months ago

Amphastar Pharmaceuticals Third Quarter 2024 Earnings: Misses Expectations

AMPH

Thomson Reuters StreetEvents

5 months ago

Q3 2024 Amphastar Pharmaceuticals Inc Earnings Call

AMPH

GuruFocus.com

5 months ago

Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Call Highlights: Resilient Revenue Growth ...

Here's What Key Metrics Tell Us About Amphastar (AMPH) Q3 Earnings
AMPH

Zacks

5 months ago

Here's What Key Metrics Tell Us About Amphastar (AMPH) Q3 Earnings

Amphastar Pharmaceuticals (AMPH) Lags Q3 Earnings and Revenue Estimates
AMPH

Zacks

5 months ago

Amphastar Pharmaceuticals (AMPH) Lags Q3 Earnings and Revenue Estimates

AMPH

Associated Press Finance

5 months ago

Amphastar: Q3 Earnings Snapshot

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024
AMPH

ACCESSWIRE

5 months ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024

AMPH

Argus Research

5 months ago

AMPH: What does Argus have to say about AMPH?

Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Report Preview: What to Expect
AMPH

GuruFocus.com

5 months ago

Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Report Preview: What to Expect

BridgeBio Pharma (BBIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
AMPH

Zacks

5 months ago

BridgeBio Pharma (BBIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Amphastar Pharmaceuticals (AMPH) Expected to Beat Earnings Estimates: Should You Buy?
AMPH

Zacks

5 months ago

Amphastar Pharmaceuticals (AMPH) Expected to Beat Earnings Estimates: Should You Buy?

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6, 2024
AMPH

ACCESSWIRE

5 months ago

Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6, 2024

Are Investors Undervaluing Amphastar Pharmaceuticals (AMPH) Right Now?
AMPH

Zacks

5 months ago

Are Investors Undervaluing Amphastar Pharmaceuticals (AMPH) Right Now?

Will Amphastar (AMPH) Beat Estimates Again in Its Next Earnings Report?
AMPH

Zacks

5 months ago

Will Amphastar (AMPH) Beat Estimates Again in Its Next Earnings Report?

Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock Is Going Strong: Is the Market Following Fundamentals?
AMPH

Simply Wall St.

6 months ago

Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock Is Going Strong: Is the Market Following Fundamentals?

Is Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) The Top Stock With Improving Technical Ratings According To Piper Sandler?
AMPH

Insider Monkey

6 months ago

Is Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) The Top Stock With Improving Technical Ratings According To Piper Sandler?

AMPH

Argus Research

6 months ago

AMPH: Lowering target price to $49.00

Implied Volatility Surging for Amphastar Pharmaceuticals (AMPH) Stock Options
AMPH

Zacks

6 months ago

Implied Volatility Surging for Amphastar Pharmaceuticals (AMPH) Stock Options

Amphastar Pharmaceuticals (NASDAQ:AMPH) jumps 10% this week, though earnings growth is still tracking behind three-year shareholder returns
AMPH

Simply Wall St.

6 months ago

Amphastar Pharmaceuticals (NASDAQ:AMPH) jumps 10% this week, though earnings growth is still tracking behind three-year shareholder returns

Insider Sale: Director Floyd Petersen Sells Shares of Amphastar Pharmaceuticals Inc (AMPH)
AMPH

GuruFocus.com

7 months ago

Insider Sale: Director Floyd Petersen Sells Shares of Amphastar Pharmaceuticals Inc (AMPH)

Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference
AMPH

ACCESSWIRE

7 months ago

Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference

AMPH

Argus Research

7 months ago

AMPH: Raising target price to $51.00

AMPH

Argus Research

7 months ago

AMPH: Raising target price to $48.00

AMPH

MT Newswires

8 months ago

Amphastar Pharmaceuticals Insider Sold Shares Worth $736,550, According to a Recent SEC Filing

Amphastar Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
AMPH

Simply Wall St.

8 months ago

Amphastar Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Compared to Estimates, Amphastar (AMPH) Q2 Earnings: A Look at Key Metrics
AMPH

Zacks

8 months ago

Compared to Estimates, Amphastar (AMPH) Q2 Earnings: A Look at Key Metrics

Amphastar Pharmaceuticals (AMPH) Tops Q2 Earnings and Revenue Estimates
AMPH

Zacks

8 months ago

Amphastar Pharmaceuticals (AMPH) Tops Q2 Earnings and Revenue Estimates

AMPH

Associated Press Finance

8 months ago

Amphastar: Q2 Earnings Snapshot

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2024
AMPH

ACCESSWIRE

8 months ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2024

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2024
AMPH

ACCESSWIRE

8 months ago

Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 7, 2024

AMPH

Argus Research

8 months ago

AMPH: Raising target price to $43.00

AMPH

Argus Research

9 months ago

AMPH: Raising target price to $42.00

Why Amphastar (AMPH) is Poised to Beat Earnings Estimates Again
AMPH

Zacks

9 months ago

Why Amphastar (AMPH) is Poised to Beat Earnings Estimates Again

3 Generic Drug Stocks to Watch Amid Improving Market Prospects
AMPH

Zacks

9 months ago

3 Generic Drug Stocks to Watch Amid Improving Market Prospects

AMPH

Argus Research

9 months ago

AMPH: What does Argus have to say about AMPH?

AMPH

Argus Research

9 months ago

AMPH: Lowering target price to $39.00

AMPH

GuruFocus.com

9 months ago

Insider Sale: CFO, EVP & Treasurer William Peters Sells Shares of Amphastar Pharmaceuticals ...

Insider Sale: Director Floyd Petersen Sells Shares of Amphastar Pharmaceuticals Inc (AMPH)
AMPH

GuruFocus.com

10 months ago

Insider Sale: Director Floyd Petersen Sells Shares of Amphastar Pharmaceuticals Inc (AMPH)

With EPS Growth And More, Amphastar Pharmaceuticals (NASDAQ:AMPH) Makes An Interesting Case
AMPH

Simply Wall St.

10 months ago

With EPS Growth And More, Amphastar Pharmaceuticals (NASDAQ:AMPH) Makes An Interesting Case

Flash News: OKX Launches 'Trade and Earn' Campaign Featuring 2,500,000 Ultiverse Tokens
AMPH

GlobeNewswire

10 months ago

Flash News: OKX Launches 'Trade and Earn' Campaign Featuring 2,500,000 Ultiverse Tokens

Advantech Releases FWA-3051, The Latest 1U Rackmount Edge Networking Solution with Intel® Xeon® D-2700/2800 Series
AMPH

PR Newswire

10 months ago

Advantech Releases FWA-3051, The Latest 1U Rackmount Edge Networking Solution with Intel® Xeon® D-2700/2800 Series

Sustainable Construction Practices and Modular Techniques Drive Dry Construction Market to $127.69 Billion by 2029
AMPH

GlobeNewswire

10 months ago

Sustainable Construction Practices and Modular Techniques Drive Dry Construction Market to $127.69 Billion by 2029

Hydrogen Storage Market Set to Hit $6.8 Billion by 2031, registering a solid CAGR of 23% - Exclusive Report by Coherent Market Insights
AMPH

GlobeNewswire

10 months ago

Hydrogen Storage Market Set to Hit $6.8 Billion by 2031, registering a solid CAGR of 23% - Exclusive Report by Coherent Market Insights

Shake Shack (SHAK) Rose after Strong Q4 Results
AMPH

Insider Monkey

10 months ago

Shake Shack (SHAK) Rose after Strong Q4 Results

Flash News: OKX to List Ultiverse's Token on its Perpetual Futures Market, Expanding Trading Options
AMPH

GlobeNewswire

10 months ago

Flash News: OKX to List Ultiverse's Token on its Perpetual Futures Market, Expanding Trading Options

"Green Energy" Brings Charging Piles to Mountain Villages
AMPH

PR Newswire

10 months ago

"Green Energy" Brings Charging Piles to Mountain Villages

Global UV-Curable Adhesives Market Report 2024: Rising Demand in Electronics and Packaging Drives UV-Curable Adhesives Market to $605.4 Million by 2032
AMPH

GlobeNewswire

10 months ago

Global UV-Curable Adhesives Market Report 2024: Rising Demand in Electronics and Packaging Drives UV-Curable Adhesives Market to $605.4 Million by 2032

AMPH

MT Newswires

10 months ago

Amphastar Pharmaceuticals' Board Approves $50 Million Increase to Share Buyback Plan

Amphastar Announces Additional $50 Million Increase to its Share Buyback Program
AMPH

ACCESSWIRE

10 months ago

Amphastar Announces Additional $50 Million Increase to its Share Buyback Program

Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
AMPH

ACCESSWIRE

10 months ago

Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

AMPH

MT Newswires

10 months ago

Amphastar Pharmaceuticals Gains US FDA Approval for Generic Bronchospasm Drug

Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol
AMPH

ACCESSWIRE

10 months ago

Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol

Implied Volatility Surging for Amphastar (AMPH) Stock Options
AMPH

Zacks

a year ago

Implied Volatility Surging for Amphastar (AMPH) Stock Options

AMPH

GuruFocus.com

a year ago

Amphastar Pharmaceuticals Reports Strong First Quarter Earnings, Surpassing Analyst Revenue ...

Amphastar Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.90 (vs US$0.54 in 1Q 2023)
AMPH

Simply Wall St.

a year ago

Amphastar Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.90 (vs US$0.54 in 1Q 2023)

Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care Conference
AMPH

ACCESSWIRE

a year ago

Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care Conference

Share on Social Networks: